ReviewMedicine2017
Clinicopathological features and differential diagnosis of aggressive angiomyxoma of the female pelvis: 5 case reports and literature review.
Review in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Case Report: A Rare Recurrent Vaginal Angiomyofibroblastoma.Journal of clinical ultrasound : JCU · 2026Article
- Article
- Vulvar Aggressive Angiomyxoma in a Postmenopausal Woman: Diagnostic Pitfalls and Surgical Implications-A Case Report.Case reports in obstetrics and gynecology · 2026Article
- Article
- MR imaging of benign vulvar lesions: a pictorial essay.Abdominal radiology (New York) · 2025Review
- Imaging features of a rare giant intra-abdominal aggressive angiomyxoma.Radiology case reports · 2024Article
- Article
- Vulval Aggressive Angiomyxoma in a 19 year teenager: a case report.BMC women's health · 2022Article
- Review
- Article
- Aggressive angiomyxoma of the stomach: a novel site of a rare neoplasm.BMJ case reports · 2022Article
- Aggressive Angiomyxoma in the Scrotum: A Case Series and Literature Review.Frontiers in surgery · 2022Article
- Radio-pathological and Clinical Correlation of Aggressive Angiomyxoma: Experience of a Tertiary Care Cancer Hospital.The Indian journal of radiology & imaging · 2021Article
- Aggressive angiomyxoma of left buttock.BMJ case reports · 2021Article
- Aggressive angiomyxoma presenting as posterior vaginal prolapse.International urogynecology journal · 2019Article
- Application of ultrasound in aggressive angiomyxoma: Eight case reports and review of literature.World journal of clinical cases · 2018Article
- Robotic extralevator excision of a retrorectal giant aggressive angiomyxoma.Obstetrics & gynecology science · 2018Article
- A persistent mass: A case of aggressive Angiomyxoma of the vulva.Gynecologic oncology reports · 2018Article
- Vaginal Angiomyofibroblastoma: A Case Report and Review of Diagnostic Imaging.Case reports in obstetrics and gynecology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aggressive angiomyxoma (AAM) is a rare mesenchymal tumor that usually occurs in the pelvis and perineum of young females. AAM can simulate Bartholin's gland cyst, abscess, lipoma, simple labial cyst, or other pelvic soft tissue tumors. Here we present five cases of AAM with mean age of 42. The patients mainly presented slow-growing mass in the abdomen and perineum (3 cases in the pelvis, 1 in the vulva, and 1 in the buttock). Color Doppler flow imaging revealed blood flow for the 3 pelvic lesions. Enhanced computed tomography and magnetic resonance imaging of the other 2 cases showed the typical "swirled" or "layered" structure characteristic. Through the pathological examination, its positivity to estrogen and progesterone receptors can justify enlargement and recurrence, confirming the tumor is AAM. All 5 patients underwent local tumor resection. Two patients recurred 8 and 15 months after surgery, respectively. The longest follow-up was 42 months. Although few cases are reported, early recognition demands high index of suspicion for both gynaecologists and pathologists. Wide surgical excision with tumor free margins is the basis of curative treatment. Adjuvant therapy may be necessary for residual or recurrent tumors. Long-term follow-up is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.